Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Dec;74(12):2003–2007. doi: 10.1038/bjc.1996.667

Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Y Hirono 1, S Fushida 1, Y Yonemura 1, H Yamamoto 1, H Watanabe 1, A Raz 1
PMCID: PMC2074811  PMID: 8980404

Abstract

Up-regulation of autocrine motility factor receptor (AMF-R) expression has been shown to be associated with invasion and metastasis of experimental tumour systems and human neoplasms. Monoclonal antibodies against AMF-R (gp78) were used to stain 221 primary gastric cancer specimens, and level of expression was examined in relation to pathological stage and prognostic values. In 125 out of 221 (56.6%) patients, gp78 was detected. Expression of gp78 was associated with macroscopic type, lymphatic and venous invasions, and lymph node and peritoneal metastasis. The level of gp78 expression in the cancer specimens was associated with histopathological stage and grade of tumour penetration. Positive gp78 expression was significantly associated with poor prognosis (P < 0.001). This significant relationship remained among patients in stage II and III. The results suggest that gp78 expression could be used as a prognostic marker in gastric cancer patients.

Full text

PDF
2003

Images in this article

2004Figure 1
on p.2004
2004Figure 2
on p.2004

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi Y., Kamakura T., Mori M., Maehara Y., Sugimachi K. Role of lymph node dissection and splenectomy in node-positive gastric carcinoma. Surgery. 1994 Nov;116(5):837–841. [PubMed] [Google Scholar]
  2. Baba H., Maehara Y., Takeuchi H., Inutsuka S., Okuyama T., Adachi Y., Akazawa K., Sugimachi K. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery. 1995 Feb;117(2):165–169. doi: 10.1016/s0039-6060(05)80080-7. [DOI] [PubMed] [Google Scholar]
  3. Fidler I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990 Oct 1;50(19):6130–6138. [PubMed] [Google Scholar]
  4. Fujimura T., Yonemura Y., Fushida S., Urade M., Takegawa S., Kamata T., Sugiyama K., Hasegawa H., Katayama K., Miwa K. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer. 1990 Jan 1;65(1):65–71. doi: 10.1002/1097-0142(19900101)65:1<65::aid-cncr2820650115>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  5. Hallissey M. T., Dunn J. A., Ward L. C., Allum W. H. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet. 1994 May 28;343(8909):1309–1312. doi: 10.1016/s0140-6736(94)92464-3. [DOI] [PubMed] [Google Scholar]
  6. Hart I. R., Goode N. T., Wilson R. E. Molecular aspects of the metastatic cascade. Biochim Biophys Acta. 1989 Jul 28;989(1):65–84. doi: 10.1016/0304-419x(89)90035-8. [DOI] [PubMed] [Google Scholar]
  7. Liotta L. A., Mandler R., Murano G., Katz D. A., Gordon R. K., Chiang P. K., Schiffmann E. Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A. 1986 May;83(10):3302–3306. doi: 10.1073/pnas.83.10.3302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maehara Y., Okuyama T., Oshiro T., Baba H., Adachi Y., Sugimachi K. Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer. Oncology. 1994 Jul-Aug;51(4):366–371. doi: 10.1159/000227367. [DOI] [PubMed] [Google Scholar]
  9. Maruyama K., Watanabe H., Shiozaki H., Takayama T., Gofuku J., Yano H., Inoue M., Tamura S., Raz A., Monden M. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. Int J Cancer. 1995 Oct 20;64(5):316–321. doi: 10.1002/ijc.2910640506. [DOI] [PubMed] [Google Scholar]
  10. Mooradian D. L., McCarthy J. B., Komanduri K. V., Furcht L. T. Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J Natl Cancer Inst. 1992 Apr 1;84(7):523–527. doi: 10.1093/jnci/84.7.523. [DOI] [PubMed] [Google Scholar]
  11. Nabi I. R., Watanabe H., Raz A. Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev. 1992 Mar;11(1):5–20. doi: 10.1007/BF00047599. [DOI] [PubMed] [Google Scholar]
  12. Nabi I. R., Watanabe H., Raz A. Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res. 1990 Jan 15;50(2):409–414. [PubMed] [Google Scholar]
  13. Nabi I. R., Watanabe H., Silletti S., Raz A. Tumor cell autocrine motility factor receptor. EXS. 1991;59:163–177. doi: 10.1007/978-3-0348-7494-6_11. [DOI] [PubMed] [Google Scholar]
  14. Nakamori S., Watanabe H., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., Kabuto T., Raz A. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer. 1994 Oct 1;74(7):1855–1862. doi: 10.1002/1097-0142(19941001)74:7<1855::aid-cncr2820740705>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  15. Nakazato H., Koike A., Saji S., Ogawa N., Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet. 1994 May 7;343(8906):1122–1126. doi: 10.1016/s0140-6736(94)90233-x. [DOI] [PubMed] [Google Scholar]
  16. Nekarda H., Schmitt M., Ulm K., Wenninger A., Vogelsang H., Becker K., Roder J. D., Fink U., Siewert J. R. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res. 1994 Jun 1;54(11):2900–2907. [PubMed] [Google Scholar]
  17. Ninomiya I., Endo Y., Yonemura Y., Noguchi M., Fushida S., Nakai M., Takamura H., Harada F., Suzuki T., Miyazaki I. Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription. Br J Cancer. 1992 Jul;66(1):84–87. doi: 10.1038/bjc.1992.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nomura H., Sato H., Seiki M., Mai M., Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995 Aug 1;55(15):3263–3266. [PubMed] [Google Scholar]
  19. Otto T., Birchmeier W., Schmidt U., Hinke A., Schipper J., Rübben H., Raz A. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res. 1994 Jun 15;54(12):3120–3123. [PubMed] [Google Scholar]
  20. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994 Jul 7;370(6484):61–65. doi: 10.1038/370061a0. [DOI] [PubMed] [Google Scholar]
  21. Sato Y., Rifkin D. B. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol. 1988 Sep;107(3):1199–1205. doi: 10.1083/jcb.107.3.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Seppä H., Grotendorst G., Seppä S., Schiffmann E., Martin G. R. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol. 1982 Feb;92(2):584–588. doi: 10.1083/jcb.92.2.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Silletti S., Raz A. Autocrine motility factor is a growth factor. Biochem Biophys Res Commun. 1993 Jul 15;194(1):446–457. doi: 10.1006/bbrc.1993.1840. [DOI] [PubMed] [Google Scholar]
  24. Silletti S., Watanabe H., Hogan V., Nabi I. R., Raz A. Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res. 1991 Jul 1;51(13):3507–3511. [PubMed] [Google Scholar]
  25. Stracke M. L., Engel J. D., Wilson L. W., Rechler M. M., Liotta L. A., Schiffmann E. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem. 1989 Dec 25;264(36):21544–21549. [PubMed] [Google Scholar]
  26. Stracke M. L., Krutzsch H. C., Unsworth E. J., Arestad A., Cioce V., Schiffmann E., Liotta L. A. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem. 1992 Feb 5;267(4):2524–2529. [PubMed] [Google Scholar]
  27. Turley E. A., Austen L., Vandeligt K., Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol. 1991 Mar;112(5):1041–1047. doi: 10.1083/jcb.112.5.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Watanabe H., Carmi P., Hogan V., Raz T., Silletti S., Nabi I. R., Raz A. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem. 1991 Jul 15;266(20):13442–13448. [PubMed] [Google Scholar]
  29. Watanabe H., Kanbe K., Chigira M. Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma. Clin Exp Metastasis. 1994 Mar;12(2):155–163. doi: 10.1007/BF01753982. [DOI] [PubMed] [Google Scholar]
  30. Watanabe H., Nabi I. R., Raz A. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res. 1991 May 15;51(10):2699–2705. [PubMed] [Google Scholar]
  31. Weidner K. M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7001–7005. doi: 10.1073/pnas.88.16.7001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yonemura Y., Katayama K., Kamata T., Fushida S., Segawa M., Ooyama S., Miwa K., Miyazaki I. Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node. Int Surg. 1991 Oct-Dec;76(4):222–225. [PubMed] [Google Scholar]
  33. Yonemura Y., Ooyama S., Matumoto H., Kamata T., Kimura H., Takegawa S., Kosaka T., Yamaguchi A., Miwa K., Miyazaki I. Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach. Int Surg. 1991 Oct-Dec;76(4):226–229. [PubMed] [Google Scholar]
  34. de Aretxabala X., Konishi K., Yonemura Y., Ueno K., Yagi M., Noguchi M., Miwa K., Miyazaki I. Node dissection in gastric cancer. Br J Surg. 1987 Sep;74(9):770–773. doi: 10.1002/bjs.1800740904. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES